409
Participants
Start Date
Not specified
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
TAK-438
TAK-438 20 mg, tablets, orally, once daily for up to 8 weeks.
Placebo
"Lansoprazole placebo-matching capsules, orally, once daily for up to 8 weeks.~For participants whose EE is not endoscopically healed at Week 8, the participants will receive additional treatment of TAK-438 40 mg, tablets, orally, once daily for up to an additional 8 weeks."
Lansoprazole
"Lansoprazole 30 mg, capsules, orally, once daily for up to 8 weeks.~For participants whose EE is not endoscopically healed at Week 8, the participants will receive additional treatment of TAK-438 40 mg, tablets, orally, once daily for up to an additional 8 weeks."
Placebo
TAK-438 placebo-matching tablets, orally, once daily for up to 8 weeks.
Nagoya
Abiko-shi
Fukuoka
Itoshima-shi
Kurume-shi
Onga-gun
Gifu
Annaka-shi
Aki-gun
Hiroshima
Sapporo
Amagasaki-shi
Kobe
Takarazuka-shi
Sakade-shi
Yokohama
Kochi
Susaki-shi
Kumamoto
Kyoto
Nagasaki
Ōita
Okayama
Fuziidera-shi
Shizuoka
Otawara-shi
Chiyoda-ku
Chuo-ku
Nakano-ku
Ōta-ku
Setagaya-ku
Yamagata
Lead Sponsor
Takeda
INDUSTRY